Trademark Overview
On Thursday, February 20, 2025, a trademark application was filed for ZYANBII with the United States Patent and Trademark Office. The USPTO has given the ZYANBII trademark a serial number of 99048590. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 20, 2025. This trademark is owned by Zenas BioPharma, Inc.. The ZYANBII trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical and biological preparations; Pharmaceutical and biological preparations for use in inflammation, immunology, rheumatology, neurology, gastroenterology, dermatology, and hematology; Therapeutic agents, namely, monoclonal antibodies for inhibiting the production and proliferation of autoantibodies, cytokine secretion, and other inflammatory proteins, and antigen uptake; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing autoimmune diseases, inflammatory diseases, immunoglobulin G4-related disease (IgG4-RD), multiple sclerosis, lupus, autoimmune hemolytic anemia, rheumatoid arthritis, and diseases, disorders, and conditions of the immune system
